TECHBio-Techne
$72.79+20% 1Y
$72.79
$43.2252 weeks$72.79
Latest close: a new 52-week highNov 6, 2026what changed →
Valuation
What TECH's price assumes
Bio-Techne trades at 66.8× earnings against 20.8× for the median Biotechnology name.
66.8
Trailing P/E · Biotechnology median 20.8 · 3.21× the Biotechnology median
- Price / sales
- 9.29
Price / sales · today's price, trailing year to Sep 30, 2026
- Free cash flow yield
- 2.7%
Free cash flow yield · Biotechnology median 3.4%
- Growth the price implies
- +14%
Growth the price implies · The price pays for +14% free cash flow growth a year for a decade; the business has delivered +13% a year over the last three.
Details›
- Price / booktoday's price, trailing year to Sep 30, 2026
- 5.27
- EV / EBITtoday's price, trailing year to Sep 30, 2026
- 46.8
- EV / salestoday's price, trailing year to Sep 30, 2026
- 9.17
- Healthcare median P/E497 names
- 27.1
- Biotechnology median P/E238 names
- 20.8
- Free cash flow, trailing twelve months
- $308M
- Market capitalisation156.8 million shares, counted Aug 17, 2026
- $11.4B
- 3-year revenue growth
- +2.4%
- 3-year free cash flow growth
- +13%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Against its own past
Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.
On our screensStocks with more cash than debt
Biotechnology
The closest names by size in the same industry